Share
The JCEM Case Reports Clinical Pearls session at ENDO 2025 featured three presentations of rare challenging endocrine cases that could answer questions for endocrinologists who could be treating patients with similar symptoms, possibly triggering further investigations that might lead to optimal outcomes. The audience for the third-annual JCEM Case Reports Clinical Pearls session at ENDO...
Share
From the pages of the Journal of the Endocrine Society, Endocrine News talks with Alan Rogol, MD, PhD, about the rarest of rare cases that involved growth hormone, Creutzfeldt-Jakob disease, and Alzheimer disease in a tale through time that involves rats, cadavers, and how one treatment evolved through scientific refinement. Has there ever been a...
Share
A recent clinical trial reveals encouraging news for a Cushing’s disease treatment A poster from ENDO 2025 showed that osilodrostat provides sustained clinical benefits in Cushing’s patients who experienced positive outcomes by the end of the treatment period. Richard Auchus, MD, PhD, discusses how the data reinforces the drug’s use, which was well-tolerated for extended...
Share
The U.S. Food and Drug Administration (FDA) recently granted a New Drug Application (NDA) for a hydrocortisone oral solution Eton Pharmaceuticals, Inc. is marketing as KHINDIVI™ — a replacement therapy in pediatric patients five years of age and older with adrenocortical insufficiency. KHINDIVI is the only FDA-approved oral solution formulation of hydrocortisone. It comes in a 1mg/ml...
Share
ENDO 2025 mines endocrine breakthroughs and breakouts in San Francisco When the biggest endocrinology conference in the world happens, professionals from around the world take notice! Over 7,000 endocrinologists hit the jackpot in San Francisco the second week in July for ENDO 2025 where there were more than just a few “eureka moments! People have...
Share
Endocrine Society experts encouraged more widespread screening for primary aldosteronism – a common hormonal cause of high blood pressure — in a new Clinical Practice Guideline presented during a packed session on the last day of ENDO 2025 in San Francisco and appearing in this month’s Journal of Clinical Endocrinology & Metabolism. William F. Young,...
Share
People who skip breakfast and eat late dinners may have an increased risk of developing osteoporosis, according to a new study published in the Journal of the Endocrine Society. Lifestyle habits, such as exercise, alcohol consumption and smoking, are known to increase people’s risk of osteoporosis, however little is known about the association between osteoporotic fracture...
Share
As the prevalence of type 2 diabetes and liver disease continues to increase, so too does the awareness of the bidirectional relationship between these two diseases. Endocrine News speaks to Priyanka Majety, MD, about her recent paper detailing this relationship, and how endocrinologists are uniquely positioned to break the cycle. In her practice, Priyanka Majety,...
